Muscle relaxants

Best Practice and Research: Clinical Anaesthesiology

Volumn 17, Issue 1, 2003, Pages 137-146

  Kampe, Sandra ^a   Krombach, Jens W ^b   Diefenbach, Christoph ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c St Katharinen Hospital   (Germany)

Author keywords

Carcinogenicity; Cytotoxic effects; Enzyme inhibition; Long term administration; Malignant hyperthermia; Muscle relaxants; Side effect; Teratogenicity; toxicity

Indexed keywords

4 BENZYLISOQUINOLINE DERIVATIVE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALCURONIUM; ANESTHETIC AGENT; ATRACURIUM; CISATRACURIUM; CREATINE KINASE; ENFLURANE; FENTANYL; GALLAMINE; HISTAMINE; LAUDANOSINE; MIVACURIUM; MUSCARINIC RECEPTOR; MUSCLE RELAXANT AGENT; MYOGLOBIN; NEUROMUSCULAR BLOCKING AGENT; NICOTINIC RECEPTOR; PANCURONIUM; PROPOFOL; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; VECURONIUM; VECURONIUM DERIVATIVE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANESTHESIA COMPLICATION; ARTIFICIAL VENTILATION; BECKER MUSCULAR DYSTROPHY; BRAIN NERVE CELL; CARCINOGENICITY; CARDIOVASCULAR SYSTEM; CELL STIMULATION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CONVULSION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG HYPERSENSITIVITY; DRUG PENETRATION; DRUG RECEPTOR BINDING; DUCHENNE MUSCULAR DYSTROPHY; ENZYME DEFECT; EXPERIMENTAL DESIGN; FETOTOXICITY; GANGLION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HISTAMINE RELEASE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; LETHAL DOSE; MALIGNANT HYPERTHERMIA; MASSETER MUSCLE; MAST CELL; MOTOR NEUROPATHY; MUSCLE ATROPHY; MUSCLE SPASM; MUSCLE WEAKNESS; MYALGIA; MYOGLOBINURIA; MYOPATHY; MYOTONIA; NERVE CELL NECROSIS; NERVE STIMULATION; NERVOUS SYSTEM; NEUROTOXICITY; NONHUMAN; PLACENTA; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SEIZURE; SINUS BRADYCARDIA; SKELETAL MUSCLE; TERATOGENICITY; TISSUE INJURY; ANIMAL; BRAIN; CONGENITAL MALFORMATION; DRUG EFFECT; FETUS; MUSCLE CELL;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BRAIN; CARDIOVASCULAR SYSTEM; FETUS; HISTAMINE RELEASE; HUMANS; MUSCLE CELLS; NEUROMUSCULAR BLOCKING AGENTS;

EID: 0038725604     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2003.0272     Document Type: Article

References (76)

1. Betcher A.M. The historic misuse of anaesthetic and related agents In Atkinson R S Boulton TB (Eds.), The History of Anaesthesia 1989 223-229 Royal Society of Medicine Service Lim New York
2. Skarpa M. Dayan A.D. Follenfant M. et al.Toxicity testing of atracurium British Journal of Anaesthesia 55 1983 27S-29S
3. Percault C Guay J Gaudreault P et al. Residual curarization in the neonate after caesarean section Canadian Journal of Anaesthesia 38 1991 587-591
4. Dailey P.A. Fisher D.M. Shnider S.M. et al. Pharmacokinetics, placental tranfer, and neonatal effects of vecuronium and pancuronium administered during Cesarean section Anesthesiology 60 1984 569-574
5. Flynn P.J. Frank M. Hughes R. Use of atracurium in cesarean section British Journal of Anaesthesiology 56 1984 599-605
6. Abouleish E. Abbound T. Lechevalier J. et al. Rocuronium (ORG 9426) for Caesarean section British Journal of Anaesthesiology 73 1994 336-341
7. Shearer E.S. Fahey L.T. O'Sullivan E.P. Hunter J.M. Transplacental distribution of atracurium, laudanosine and monoquarternary alcohol during elective caesarean section British Journal of Anaesthesiology 66 1991 551-556
8. Ho P.C. Stephens I.D. Triggs E.J. Caesarean section and placental transfer of alcuronium Anaesthesia and Intensive Care 9 1981 113-118
9. Suzuki Y. Masuda H. Tanase H. Okonogi T. The safety test of pancuronium bromide Annals of Clinical Laboratory Science 22 1970 187-208
10. Jacobs RM Failure of muscle relaxants to produce cleft palate in mice Teratology 4 1971 25-30
11. Fujinaga M Baden JM Mazze RI Development toxicity of nondepolarizing muscle relaxants in cultured rat embryos Anesthesiology 76 1992 999-1003
12. Amann A Rieder J Fleischer M et al. The influence of atracurium, cisatracurium and mivacurium on the proliferation of two human cell lines in vitro Anesthesia & Analgesia 93 2001 690-696
13. Jago RH Arthrogryposis following treatment of maternal tetanus with muscle relaxants Archives of Diseases in Childhood 45 1970 227-279
14. Moya F Kvisselgaard N The placental transmission of succinylcholine Anesthesiology 22 1961 1-6
15. Thomas J Climic CR Mather LE The placenta transfer of alcuronium: a preliminary report British Journal of Anaesthesia 41 1969 297-302
16. Older PO Harris JM. Placental transfer of tubocurarine: a case report British Journal of Anaesthesia 40 1968 459-463
17. Anselmi E. Fayos G. Blasco R. et al. Selective inhibition of calcium entry induced by benzylisochinolines in rat smooth muscle Journal of Pharmacy and Pharmacology 44 1992 337-343
18. Britt B.A. Kalow W. Malignant hyperthermia: a statistical review Canadian Anesthesiologists' Society Journal 17 1970 293-315
19. Ording H. Diagnosis of susceptibility to malignant hyperthermia in man British Journal of Anaesthesia 60 1988 287-302
20. Klein W. Spiess-Kiefer C. Kuether G. et al. Diagnose der Anlage zur Maligner Hyperthermie mit Hilfe des in vitro-Kontrakturtests Anaesthesist 36 1987 685-691
21. Lehmann-Horn F. Iaizzo P.A. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia? British Journal of Anaesthesia 65 1990 692-697
22. Takagi A. Sunohara N. Ishihara T. et al. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers Muscle & Nerve 6 1983 510-514
23. Laurence A.S. Myalgia and biochemical changes following intermittent suxamethonium administration Anaesthesia 42 1987 503-510
24. Ryan J.F. Kagen L.J. Hyman A.I. Myoglobinemia after single dose of succinylcholine New England Journal of Medicine 285 1971 824-827
25. Waters D.J. Mapleson W.W. Suxamethonium pains: hypothesis and observation Anaesthesia 26 1971 127-141
26. Collier C.B. Suxamethonium and early electrolyte changes Anaesthesia 33 1978 454-461
27. Collier C.B. Suxamethonium pain and fasciculations Proceedings of the Royal Society of Medicine 68 1975 105-108
28. Maddineni V.R. Mirakhur R.K. Cooper A.R. Myalgia and biochemical changes following suxamethonium after induction of anaesthesia with thiopentone or propofol Anaesthesia 48 1993 626-628
29. McLoughlin C. Mirakhur R.K. Trimble E.R. Clarke S.J. Pathogenesis of suxamethonium-induced muscle damage in the biventer cervicis muscle in the chick British Journal of Anaesthesia 67 1991 764-767
30. Budd A. Scott R.F.P. Blogg C.E. Goat V.A. Adverse effects of suxamethonium-failure of prevention by atracurium or fazidinium Anaesthesia 40 1987 642-646
31. Tammisto T. Airaksinen M. Increase of creatine kinase activity in serum as a sign of muscular injury caused by intermittently administered suxamethonium during halothane anaesthesia British Journal of Anaesthesia 38 1966 510-515
32. McLoughlin C. Leslie K. Caldwell J.E. Influence of dose on suxamethonium-induced muscle damage British Journal of Anaesthesia 73 1994 194-198
33. Sutherland R.W. Effect of induction of anaesthesia with propofol on suxamethonium-induced myalgia British Journal of Anaesthesia 71 1993 765P-766P
34. Gronert G.A. Antognini J.F. Pessah I.N. Malignant hyperthermia In Miller R D (Ed.), Anesthesia 2000 1033-1052 Churchill Livingstone Philadelphia
35. Pedrozzi N.E. Ramelli G.P. Tomasetti R. et al. Rhabdomyolysis and anesthesia: a report of two cases and review of the literature Pediatric Neurology 15 1996 254-257
36. Fisher D.M. Should succinylcholine continue to be used routinely in pediatric anesthesia? In Rupp SM (Ed.), Problems in Anesthesia. Neuromuscular Relaxants 1989 394-404 J.B. vol. 3, no.3 Lippincott Philadelphia
37. Nigrovic V. Pandya J.B. Klaunig J.E. Fry K. Reactivity and toxicity of atracurium and its metabolites in vitro Canadian Journal of Anaesthesia 36 1989 262-268
38. Reckendorfer H. Burgmann H. Sperlich M. et al. Hepatotoxicity testing of atracurium and laudanosine in the isolated, perfused rat liver British Journal of Anesthesia 69 1992 288-291
39. Matteo R.S. Pua E.K. Khambatta H.J. Spector S Cerebrospinal fluid levels of d-tubocurarine in man Anesthesiology 46 1977 396-399
40. Caldwell J.E. Personal correspondence
41. Morikawa N. Nakagawa-Hattori Y. Mizuno Y. Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity Journal of Neurochemistry 66 1996 1174-1181
42. Peduto V.A. Gungui P. Martino M.R. Napoleone M. Accidental subarachnoid injection of pancuronium Anesthesia & Analgesia 69 1989 516-517
43. Goonewardene T.W. Sentheshanmuganathan S. Kamalathan S. Kanagasundereram R. Accidental subarachnoidal injection of gallamine: a case report British Journal of Anaesthesia 47 1975 889-893
44. Salama S. Wright S. Action of d-tubocurarine chloride on the CNS of the cat British Journal of Pharmacology 5 1950 49-52
45. Dasheiff RM D-Tubocurarine causes neuronal death when injected directly into rat brain Experimental Neurology 89 1985 172-188
46. Hansen-Flaschen J Cowen J Raps EC Neuromuscular blockade in the intensive care unit. More than we bargained for American Review of Respiratory Diseases 147 1993 234-236
47. Caldwell JE Szenohradszky J Segredo V et al. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (Org 7268) and its parent compound, vecuronium, in human volunteers Journal of Pharmacology and Experimental Therapeutics 270 1994 1216-1222
48. Segredo V Caldwell JE Matthay MA et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium New England Journal of Medicine 327 1992 524-528
49. Hirano M. Ott B.R. Raps E.C. et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both Neurology 42 1992 2082-2087
50. Op de Coul A.A. Verhaul G.A. Leyten A.C. et al. Critical illness polyneuromyopathy after artificial respiration Clinical Neurology & Neurosurgery 93 1991 27-33
51. Zochodne D.W. Bolton C.F. Wells G.A. et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure Brain 110 1987 819-841
52. Savarese J.J. Caldwell J.E. Lien C.A. Miller R.D. Pharmacology of muscle relaxants and their antagonists In Miller RD (Ed.), Anesthesia 2000 1033-1052 Churchill Livingstone Philadelphia
53. Ostergaard D. Engbaek J. Viby-Mogensen J. Adverse reactions and interactions of the neuromuscular blocking drugs Medical Toxicology and Adverse Drug Experience 4 1989 351-368
54. Savarese JJ The autonomic margin of safety of metocurine and d-tubocurarine in the cat Anesthesiology 5 1979 40-46
55. Hughes R Chapple DJ Effect of non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats British Journal of Anaesthesia 48 1976 59-68
56. Thomson I.R. Putnins C.L. Adverse Effects of Pancuronium during high-dose fentanyl anesthesia for coronary artery bypass grafting Anesthesiology 62 1985 708-713
57. Galindo A.H.F. Davis T.B. Succinylcholine and cardiac excitability Anesthesiology 23 1962 32-36
58. Mathias J.A. Evans-Prosser C.D. Churchill-Davidson H.C. The role of the non-depolarizing drugs in the prevention of suxamethonium bradycardia British Journal of Anaesthesia 42 1970 609-612
59. Cardone C. Szenohradszky J. Yost S. Bickler P.E. Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity Anesthesiology 80 1994 1155-1161
60. Fahey M.R. Claver Canfell P. Taboada T. et al. Cerebrospinal fluid concentrations of laudanosine after administration of atracurium British Journal of Anaesthesia 64 1990 105-106
61. Katz Y. Weizman A. Pick C.G. et al. Interactions between laudanosine, GABA, and opiod subtype receptors: implication for laudanosine seizure activity Brain Research 64 1994 235-241
62. Chiodini F. Charpentier E. Muller D. et al. Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine Anesthesiology 94 2001 643-651
63. Fodale V Santamaria LB Laudanosine, an atracurium and cisatracurium metabolite European Journal of Anesthesiology 19 2002 466-473
64. Nicoll JM Status epilepticus following enflurane anaesthesia Anaesthesia 41 1986 927-930
65. Stovner J Oftedal N Holmboe J The inhibition of cholinesterases by pancuronium British Journal of Anaesthesia 47 1975 949-954
66. Krieg N. Krombach J. Tusk O. Biesel H. Precurarization: influence of atracurium, vecuronium and pancuronium on the duration of succinylcholine effects Anästhesiologie & Intensivmedizin 36 1995 189-194
67. Erkola O. Rautoma P. Meretoja O.A. Mivacurium when preceded by pancuronium becomes a long acting muscle relaxant Anesthesiology 84 1996 562-565
68. Motamed C. Kirov K. Lieutaud T. Duvaldestin P. The mechanism of pancuronium potentiation of mivacurium block: use of the isolated-arm technique Anesthesia & Analgesia 91 2000 732-735
69. Futo J. Kupferberg J.P. Moss J. Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants Biochemical Pharmacology 39 1990 415-420
70. Laxanaire M.C. Moneret-Vautrin D.A. Widmer S. et al. Anaesthetic drugs responsible for anaphylactic shock. French multi-center study Annales Françaises d'Anesthésie et de Reanimation 9 1990 501-506
71. Moss J. Philibin D.M. Rosow C.E. et al. Histamine release by neuromuscular blocking agents in man Klinische Wochenschrift 60 1982 891-895
72. Winbery S.L. Liebermann P. Anaphylaxis Immunology & Allergy Clinics of North America 15 1995 447-477
73. Jacobson J. Lindekaer A.L. Ostergaard H.A.T. et al. Management of anaphylactic shock evaluated using a full-scale anaesthesia simulator Acta Anaesthesiologica Scandinavica 45 2001 315-319
74. Clarkson A. Choonara I. Martin P. Suspected toxicity of atracurium in the neonate Paediatric Anaesthesiology 11 2001 629-663
75. Cannon J.E. Fahey M.R. Moss J. Miller R.D. Large doses of vecuronium and plasma histamine release concentrations Canadian Journal of Anaesthesia 35 1988 350-353
76. Basta SJ Modulation of histamine release by neuromuscular blocking drugs Current Opinion in Anaesthesiology 5 1992 572